|
" Autoimmunity and the Pathogenesis of Diabetes "
edited by Fredda Ginsberg-Fellner, Robert C. McEvoy.
Document Type
|
:
|
BL
|
Record Number
|
:
|
728874
|
Doc. No
|
:
|
b548627
|
Main Entry
|
:
|
edited by Fredda Ginsberg-Fellner, Robert C. McEvoy.
|
Title & Author
|
:
|
Autoimmunity and the Pathogenesis of Diabetes\ edited by Fredda Ginsberg-Fellner, Robert C. McEvoy.
|
Publication Statement
|
:
|
New York, NY: Springer New York, 1990
|
Series Statement
|
:
|
Endocrinology and Metabolism, Progress in Research and Clinical Practice, 4.
|
Page. NO
|
:
|
(xii, 296 pages 71 illustrations)
|
ISBN
|
:
|
146123218X
|
|
:
|
: 9781461232186
|
Contents
|
:
|
1. The Autoimmune Hypothesis of Insulin-Dependent Diabetes: 1965 to the Present --;Autoimmunity --;The Concept of IDDM as an Autoimmune Disease --;The Association Between IDDM and HLA --;Etiologic Factors with Implications for the Pathogenesis of IDDM --;The Autoantigen in IDDM --;Presentation of Autoantigen --;Autoantigen Recognition in IDDM --;The Effector Phase in IDDM --;Conclusion --;2. Immunogenetics and the Pathogenesis of Insulin-Dependent Diabetes Mellitus --;Genetic Background --;Environmental Factors --;Speculations on the Mechanism of IDDM Pathogenesis --;3. Association of Insulin-Dependent Diabetes Mellitus and Other Autoimmune Diseases --;IDDM and Thyroid Autoimmunity --;Other Endocrinopathies Associated with Type 1 Diabetes Mellitus --;How Does Autoimmune Disease Develop? --;Can Autoantibodies Affect More Than One Gland? Are They Mono- or Polyclonal? --;Summary and Conclusions --;4. The Humoral Anti-Islet Immune Response: Cytoplasmic Islet-Cell Antibodies: Technical Aspects and Clinical Applications --;Assays for ICA Determination --;Approaching Standardization of the Cytoplasmic ICA Test --;Clinical Application of the ICA Test --;Synopsis, Recommendations, and Conclusions --;5. The Humoral Anti-Islet Response: Biochemical Characterization --;Autoantigens Detected in Human Islets --;Autoantigens May Define Disease Specificity in Human Autoimmunity --;Western Blotting Analysis of Islet Autoantigens --;Analyzing Circulating Immune Complexes in Diabetes --;Summary --;6. The Humoral Anti-Islet Immune Response: Immunochemical Studies of Glycoconjugate Antigens --;What Are Gangliosides? --;Immunochemical Characterization of Monoclonal Antibody-Defined, Islet-Cell Antigens --;Immunochemical Properties of the Autoantigen(s) of Pancreatic Islets --;Extraction and Partial Purification of the ICA Glycolipid Antigen --;Glycolipid Antigens in Animal Models of Type I Diabetes --;Multiplicity of Antigens in Humoral Autoimmunity of Type I Diabetes --;Monoclonal Antibody-Defined, Islet-Cell Glycolipid Antigens --;Physiological Roles of Islet-Cell Gangliosides --;Antibodies to Glycolipids in Diseases Other than Type I Diabetes Mellitus --;Immunogenicity of Glycolipids --;T-Cell Reactivity to Glycolipid Antigens --;Final Comments --;7. Insulin Autoantibodies --;8. Cell-Mediated Anti-Islet-Cell Immune Response: Clinical Experience and Lessons from Animal Models --;Cell-Mediated, Anti-Beta-Cell Autoimmunity in Human Diabetes --;Diabetes Induced by Multiple, Subdiabetogenic Doses of Streptozotocin --;Diabetes in the Bio-Breeding Rat --;Diabetes in Nonobese Diabetic Mice --;Summary and Conclusions --;9. The Pathogenesis of Immunologically Mediated Diabetes --;Mechanism of the Disease Process --;Disease Recurrence Model --;Disease Recurrence in Islet Grafts is CD4 T-Cell Dependent --;Free Radical Involvement in the Disease Process --;Disease Recurrence in the Grafted Tissue: A Summary --;Lessons from Fetal Pancreas Transplantation --;Effect of Cyclosporine on Disease Recurrence --;10. Viral Pathogenesis of Insulin-Dependent Diabetes Mellitus --;Direct Cytolytic Viral Infection of Beta-Cells --;Association of Virus Infection with Autoimmune IDDM --;Persistent Infection of Pancreatic Beta-Cells and Mild Hyperglycemia --;Conclusion --;11. Immune Intervention in Diabetes: State of the Art and Future Directions --;Experimental Immunotherapy in IDDM of Recent Onset --;Open Studies of Immunomodulatory Therapies in IDDM --;Randomized Control Trials of the Effects of Cyclosporin in IDDM --;Efficacy and Safety of Immunosuppression in Remission Induction in IDDM --;Timing of Immunomodulatory Interventions in IDDM --;IDDM in Remission: Endocrine Metabolic Status and Its Possible Implications --;Strategies for Continuing Studies of Immunotherapy in IDDM --;Summary and Conclusions.
|
Abstract
|
:
|
. . . . . . . . . . . . . . ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Xl . . . . . . . . . . . . . The Autoimmune Hypothesis of Insulin-Dependent Diabetes: 1965 to the Present . . . . . . . . . . . . . . . .
|
Subject
|
:
|
Human genetics.
|
Subject
|
:
|
Immunology.
|
Subject
|
:
|
Medicine.
|
Added Entry
|
:
|
Fredda Ginsberg-Fellner
|
|
:
|
Robert C McEvoy
|
| |